Skip to content

Effect of Pilates Exercises on Stress Urinary Incontinence in Posmenopausal Women

Effect of Pilates Exercises on Stress Urinary Incontinence in Posmenopausal Women

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06376903
Enrollment
60
Registered
2024-04-22
Start date
2024-04-20
Completion date
2024-09-20
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Stress Incontinence

Brief summary

• This study will be conducted to determine the effect of pilates exercises on stress urinary incontinence in postmenopausal women

Detailed description

Pilates exercises help in the controlled movement of the core, that act as a corset and it activates both core muscle and synergistically the PFM. (Trantafylidis, 2009). There is limited evidence regarding the use of Pilates exercises for the management of stress urinary incontinence (SUI) in older women (Keri, 2013; Pyria et al, 2021). So this study will be conducted to determine the effect of Pilates exercises on SUI in postmenopausal women which provide an insight about the benefits of such exercise on postmenopausal SUI.

Interventions

OTHERPilates exercise - pelvic floor exercise - home advices

Group (A) (Study group): It will be consisted of thirty postmenopausal women suffering from mild and moderate stress urinary incontinence, will perform program of pilates exercises, 3 sessions/week (30 minutes a session ) for 12 weeks in addition to Kegel exercises (15min/three times per week/ for 12 weeks) and home care advices. • Group (B) (Controlled group): It will be consisted of thirty postmenopausal women suffering from mild and moderate stress urinary incontinence, will perform kegel exercises (15min/three times per week/ for 12 weeks) and home care advices as in group (A).

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Postmenopausal women (at least 12months after menstrual cessation), diagnosed with SUI by the gynecologist. * Their ages will range from 50-60 years old . * Their BMI will be less than 30kg/m2 . * All of them suffer from mild to moderate degree of SUI . * All of them delivered vaginally. * All are multipara with 2 or more children. * All are of sedentary life style.

Exclusion criteria

Women will be excluded from the study if they have: * Previous bladder surgery. * Post pelvic radiotherapy. * Vaginal/abdominal hysterectomy. * Vaginal infection. * Severe urinary tract infection. * Uterine Prolapse

Design outcomes

Primary

MeasureTime frameDescription
• Revised urinary incontinence scale6 weeks: It is considered one of the tools which used to diagnose SUI. It takes the five best items which loaded on the urinary leakage. The items comprising this revised scale include urine leakage related to the feeling of urgency, urine leakage related to physical activity, coughing or sneezing, small amounts of urine leakage \[drops\]) as well as two items related to frequency and amount of incontinence Scoring is by simple summation and the range of the total score is between zero and 12(0= no incontinence , 1-2= slight incontinence , 3-6= moderate incontinence , 7-9= severe incontinence , 12= very severe incontinence)

Secondary

MeasureTime frameDescription
• Quality of Life Questionnaire (QOL) for stress urinary incontinence6 weeks: it has been developed to provide detailed information on how urinary incontinence affects patients' lives. It is a valid and reliable instrument for assessing QOL in women with voiding symptoms, including urinary incontinence. It includes questions that evaluate the distress and impact of urinary incontinence in three domains: avoidance and limiting behavior, social embarrassment and psychosocial impact

Contacts

Primary ContactMANAL AHMED EL-SHAFEI, PHD
Manalpt1989@gmail.com+201220664518
Backup ContactAZZA BARAMOUD kASSAB, PHD
drazzakassab@yahoo.com+201008410312

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026